Anal Canal Squamous Cell Carcinoma — Clinical Trials

MONDO:00041322 activeLast updated: Mar 18, 2026, 10:51 AM

Anal Canal Squamous Cell Carcinoma has an emerging clinical trial program, driven by procedure and drug treatment.

Recruiting

Active Trials

Procedure2

Drug Treatment1

Biological Therapy1

2 additional trials involve behavioral, dietary, diagnostic, or observational approaches.

Phase 2

1 trials are observational or have no phase designation.

NIH1Academic/Other1Collaborative Network1

Canada2 trials

United States2 trials

Trials often recruit across multiple countries, so totals exceed the trial count.

2 of 3 Trials

Phase 2Active, Not Recruiting

Sponsor:ECOG-ACRIN Cancer Research Group

United StatesStarted: Jan 2020Est. completion: Dec 2029Updated: Mar 2026

Phase 2Active, Not Recruiting

Sponsor:National Cancer Institute (NCI)

United StatesStarted: May 2015Est. completion: Mar 2026Updated: Apr 2025

Stay informed about clinical trials for Anal Canal Squamous Cell Carcinoma.

Follow this disease to get updates when trials open, close, or change status.

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 18, 2026 at 10:51 AM